APA
Fanouriakis A., Adamichou C., Koutsoviti S., Panopoulos S., Staveri C., Klagou A., Tsalapaki C., Pantazi L., Konsta S., Mavragani C. P., Dimopoulou D., Ntali S., Katsikas G., Boki K. A., Vassilopoulos D., Konstantopoulou P., Liossis S., Elezoglou A., Tektonidou M., Sidiropoulos P., Erden A., Sfikakis P. P., Bertsias G. & Boumpas D. T. (20190110). Low disease activity-irrespective of serologic status at baseline-associated with reduction of corticosteroid dose and number of flares in patients with systemic lupus erythematosus treated with belimumab: A real-life observational study. : Seminars in arthritis and rheumatism.
Chicago
Fanouriakis Antonis, Adamichou Christina, Koutsoviti Sofia, Panopoulos Stylianos, Staveri Chrysanthi, Klagou Anastasia, Tsalapaki Christina, Pantazi Lamprini, Konsta Styliani, Mavragani Clio P, Dimopoulou Despoina, Ntali Styliani, Katsikas Georgios, Boki Kyriaki A, Vassilopoulos Dimitrios, Konstantopoulou Pinelopi, Liossis Stamatis-Nick, Elezoglou Antonia, Tektonidou Maria, Sidiropoulos Prodromos, Erden Abdulsamet, Sfikakis Petros P, Bertsias George and Boumpas Dimitrios T. 20190110. Low disease activity-irrespective of serologic status at baseline-associated with reduction of corticosteroid dose and number of flares in patients with systemic lupus erythematosus treated with belimumab: A real-life observational study. : Seminars in arthritis and rheumatism.
Harvard
Fanouriakis A., Adamichou C., Koutsoviti S., Panopoulos S., Staveri C., Klagou A., Tsalapaki C., Pantazi L., Konsta S., Mavragani C. P., Dimopoulou D., Ntali S., Katsikas G., Boki K. A., Vassilopoulos D., Konstantopoulou P., Liossis S., Elezoglou A., Tektonidou M., Sidiropoulos P., Erden A., Sfikakis P. P., Bertsias G. and Boumpas D. T. (20190110). Low disease activity-irrespective of serologic status at baseline-associated with reduction of corticosteroid dose and number of flares in patients with systemic lupus erythematosus treated with belimumab: A real-life observational study. : Seminars in arthritis and rheumatism.
MLA
Fanouriakis Antonis, Adamichou Christina, Koutsoviti Sofia, Panopoulos Stylianos, Staveri Chrysanthi, Klagou Anastasia, Tsalapaki Christina, Pantazi Lamprini, Konsta Styliani, Mavragani Clio P, Dimopoulou Despoina, Ntali Styliani, Katsikas Georgios, Boki Kyriaki A, Vassilopoulos Dimitrios, Konstantopoulou Pinelopi, Liossis Stamatis-Nick, Elezoglou Antonia, Tektonidou Maria, Sidiropoulos Prodromos, Erden Abdulsamet, Sfikakis Petros P, Bertsias George and Boumpas Dimitrios T. Low disease activity-irrespective of serologic status at baseline-associated with reduction of corticosteroid dose and number of flares in patients with systemic lupus erythematosus treated with belimumab: A real-life observational study. : Seminars in arthritis and rheumatism. 20190110.